Cardiol Therapeutics Inc. (CRDL) vs Neuronetics, Inc. (STIM)

A side-by-side comparison of Cardiol Therapeutics Inc. and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRDL vs STIM

growth of $100 · dividends reinvested · last 8y
CRDL -64.7% (-12.2%/yr)STIM -87.2% (-22.7%/yr)CRDL compounded faster over this window
050100150Start $100202120232025$35$13
CRDL STIM

CRDL vs STIM: by the numbers

  • •STIM is the larger company ($154M vs $151M market cap).
  • •Both run net losses; CRDL's is the smaller (0.00% vs -19.62% net margin).

Metrics side by side

Valuation

MetricCRDLSTIM
P/S ratioN/A0.99
P/B ratio8.928.62

Profitability

MetricCRDLSTIM
Gross margin0.00%49.12%
Operating margin0.00%-14.74%
Net margin0.00%-19.62%
ROE-155.34%-170.49%
ROIC-165.56%-22.15%

Growth (annualized)

MetricCRDLSTIM
Revenue CAGR (5Y)N/A23.26%
Total return CAGR (5Y)-18.36%-19.46%

Frequently asked

How have CRDL and STIM total returns compared?
Over the past 5 years, CRDL delivered -18.36% and STIM delivered -19.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.